Search
for
Sort by
Research 181–210 of 1000+
- Effectiveness of QR678 and QR678 Neo <sup>®</sup> with intralesional corticosteroid vs. intralesional corticosteroid alone in the treatment of alopecia areata –A randomized, comparative, prospective study
- Clinico-epidemiological and Therapeutic Aspects of Alopecia Areata in Children at the Dermatology Department, University Hospital of Antananarivo, Madagascar
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Hair Loss in Children
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
- The Economic Burden of Alopecia Areata in Romania
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- Psychosocial Aspects of Skin Conditions and Diseases
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Trichoscopy pattern in alopecia areata: A systematic review and meta‐analysis
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- Diphenylcyclopropenone and platelet‐rich plasma in the management of severe or recalcitrant alopecia areata
- The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care*
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review
- Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population
- Frontiers in alopecia areata pathobiology research
- Deciphering the Complex Immunopathogenesis of Alopecia Areata